Risk of malignancy in patients with rheumatoid arthritis after anti-tumor necrosis factor therapy: results from Korean National Health Insurance claims data

BACKGROUND/AIMS: Inhibition of tumor necrosis factor (TNF) is an effective treatment for rheumatoid arthritis (RA), but safety concerns about malignancy remain. The aim of this study was to evaluate cancer risk in RA patients treated with TNF inhibitors (TNFi), based on Korean Nationwide Health Insu...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Korean J Intern Med
Glavni autori: Jung, Seung Min, Kwok, Seung-Ki, Ju, Ji Hyeon, Park, Yong-Beom, Park, Sung-Hwan
Format: Artigo
Jezik:Inglês
Izdano: The Korean Association of Internal Medicine 2019
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6506746/
https://ncbi.nlm.nih.gov/pubmed/29172405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2016.374
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items